Streetbeat News

CVSI

CV Sciences Inc.

https://cvsciences.com/

Employees

71

Industry

All Other Miscellaneous Chemical Product and Preparation Manufacturing

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

CV Sciences reported a slight decrease in Q4 sales to $3.80 million, down 1.78% from $3.87 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 1:07 pm

Cannabis stocks experienced significant movements on March 25, 2024, with notable gainers including Beleave, Green Growth Brands, and Auxly Cannabis Group, while losers comprised Global Hemp Group, Elixinol Wellness, and SOL Global Investments. Major US-listed companies like GrowGeneration, Canopy Growth, Aurora Cannabis, OrganiGram Holdings, Greenlane Holdings, Tilray Brands, Cara Therapeutics, and Cronos Group also saw varied stock price changes.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on March 22, 2024, with notable gainers including Canopy Growth, Aurora Cannabis, and SNDL, among others. Losers included Belgravia Hartford Cap, Heritage Cannabis Holding, and Elixinol Wellness. The movements reflect the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 9:30 pm

The cannabis sector experienced mixed movements on March 21, 2024, with several companies showing significant gains while others faced steep declines. Notable gainers included Rocky Mountain High, CLS Holdings USA, and Trulieve Cannabis, with increases of 40.20%, 9.89%, and 7.96% respectively. On the downside, AusCann Group Holdings and Elixinol Wellness saw dramatic drops of 71.63% and 70.75%. The volatility reflects bearish sentiment across the cannabis space.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 9:30 pm

Marijuana stocks experienced significant gains on a bullish Monday, with Greenlane Holdings leading the surge at 31.82% increase. Notable gainers include Heritage Cannabis, Canopy Growth, and Aurora Cannabis among others. Conversely, a few companies like Rocky Mountain High and Global Compliance faced declines.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 9:30 pm

Marijuana stocks experienced significant movements on March 13, 2024, with notable gainers including Global Hemp Group, Blueberries Medical, and 4Front Ventures, among others. Conversely, MedMen Enterprises led the losers, experiencing a dramatic 90% decline. Other companies such as AusCann Group Holdings and Elixinol Wellness also saw substantial drops. The movements reflect the volatile nature of the marijuana stock market.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 9:30 pm

The cannabis sector experienced mixed movements on March 11, 2024, with several companies showing significant gains while others faced steep declines. Notably, MedMen Enterprises and AusCann Group Holdings saw dramatic drops of 90% and 87.5%, respectively. On the gainers' side, CordovaCann led with a 39.35% increase. Major US-listed companies like Eastside Distilling, Psychemedics, Corbus Pharmaceuticals, Emeren Group, Aurora Cannabis, Genetic Technologies, Scotts Miracle Gro, and Cara Therapeutics also experienced price movements.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 9:30 pm

The cannabis sector experienced significant movement on March 8, 2024, with a majority of stocks showing bullish sentiment. Notable gainers include MedMen Enterprises with a 900% increase and Cann Gr with a 232.28% rise. Conversely, Heritage Cannabis Holding led the losers, declining by 18.33%. This movement reflects a dynamic day in the cannabis market, with several companies experiencing substantial price changes.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 9:30 pm

On March 7, 2024, several cannabis stocks experienced significant price movements. Notable gainers included AusCann Group Holdings, Elixinol Wellness, and Rocky Mountain High, with increases of 766.67%, 75.49%, and 66.67% respectively. Corbus Pharmaceuticals and Emeren Group also saw notable gains on NASDAQ and NYSE. Conversely, Global Hemp Group led the losers with a 48.89% decrease, followed by Item 9 Labs and Global Compliance. Other significant losers included 22nd Century Group and Neptune Wellness Solutions on NASDAQ.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on March 6, 2024, with notable gainers including Item 9 Labs, Affinor Growers, and Rocky Mountain High, among others. Conversely, several companies faced declines, with AusCann Group Holdings leading the losers, followed by Elixinol Wellness and Neptune Wellness Solutions. The movements reflect the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.